Cargando…

What Might be the Cause for the Emerging Inflammatory Bowel Disease in Saudi Outpatients?

Detalles Bibliográficos
Autor principal:	Qin, Xiaofa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952426/ https://www.ncbi.nlm.nih.gov/pubmed/24496163 http://dx.doi.org/10.4103/1319-3767.126329

Ejemplares similares

Sewing Needle Penetration into Thorax: What Might be the Cause?
por: Rawat, JD, et al.
Publicado: (2017)

Non-alcoholic fatty liver disease in patients with inflammatory bowel disease might boost cardiovascular disease burden
por: Patoulias, Dimitrios Ioannis
Publicado: (2019)

Extraintestinal manifestations of pediatric inflammatory bowel disease in Saudi Arabia
por: Al-Mendalawi, Mahmood D.
Publicado: (2018)

Emerging Inflammatory Bowel Disease in Saudi Outpatients: A Report of 693 Cases
por: Al-Mofarreh, Mohammad A., et al.
Publicado: (2013)

Inactivation of Digestive Proteases by Deconjugated Bilirubin and the Physiological Significance of Fasting Hyperbilirubinemia
por: Qin, Xiaofa
Publicado: (2009)

Diagnostic delay of pediatric inflammatory bowel disease in Saudi Arabia—the community, the physicians, and the disease: Where's the hold-up?
por: Sardi, Mais Al, et al.
Publicado: (2019)

Impact of Pediatric Inflammatory Bowel Disease on Linear Growth: Data from a National Cohort Study in Saudi Arabia
por: Al-Mendalawi, Mahmood D.
Publicado: (2016)

Impact of Pediatric Inflammatory Bowel Disease on Linear Growth: Data from a National Cohort Study in Saudi Arabia
por: El Mouzan, Mohammad I
Publicado: (2016)

Ramosetron might be useful for treating diabetic diarrhea with a rapid small bowel transit time
por: Lee, Tae Hee, et al.
Publicado: (2013)

Remote Monitoring of Inflammatory Bowel Disease: What Kind of Patient-Reported Questionnaires Should We Use?
por: Rezazadeh Ardabili, Ashkan, et al.
Publicado: (2020)

CT on the Diamond Princess: What Might This Tell Us About Sensitivity for COVID-19?
por: Isikbay, Masis, et al.
Publicado: (2020)

Tremor in Patients with Inflammatory Bowel Disease
por: De Oliveira, Gisele R., et al.
Publicado: (2013)

Inflammatory bowel disease induced by bimekizumab
por: Wietrzykowska-Grishanovich, Dominika, et al.
Publicado: (2022)

Update on SARS-CoV-2 vaccination of patients with inflammatory bowel disease: what clinicians need to know
por: Lee, Yoo Jin, et al.
Publicado: (2022)

Familial inflammatory bowel diseases in Northwest Greece
por: Katsanos, Konstantinos H., et al.
Publicado: (2015)

Inflammatory Bowel Disease and the Risk of Herpes Zoster
por: Lai, Shih-Wei
Publicado: (2019)

Letter: Non-Nutritive Sweeteners May Have a Bell-Shaped Dose Response for Dysbiosis-Related Adverse Effects That Contributed to Discrepancies between Prospective Cohort and Randomized Controlled Studies
por: Qin, Xiaofa
Publicado: (2020)

Alterations of pulmonary function in patients with inflammatory bowel diseases
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2017)

Therapeutic drug monitoring in inflammatory bowel disease treatments
por: Wang, Meng-Yao, et al.
Publicado: (2022)

Plant-Based Diet Recommended for Inflammatory Bowel Disease
por: Chiba, Mitsuro, et al.
Publicado: (2023)

MDR1C3435T Polymorphism and Inflammatory Bowel Disease
por: Malik, Manzoor A.
Publicado: (2015)

Comment on “Prevalence of Anxiety and Depression in Patients with Inflammatory Bowel Disease”
por: Lai, Wenwen, et al.
Publicado: (2018)

Working Together to Meet the Needs of Patients With Inflammatory Bowel Diseases
por: Brenner, Erica J., et al.
Publicado: (2021)

Inflammatory bowel disease and diabetes: Is there a link between them?
por: Sang, Miao-Miao, et al.
Publicado: (2022)

Urotensin II level is elevated in inflammatory bowel disease patients
por: Zhang, Yan, et al.
Publicado: (2022)

Vedolizumab Is Safe in Elderly Veteran Patients With Inflammatory Bowel Disease
por: Leung, Kenneth, et al.
Publicado: (2021)

Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: The Picture Is Taking Shape
por: Papa, Alfredo, et al.
Publicado: (2021)

Adsorptive Leukocytapheresis in Inflammatory Bowel Diseases: Our Preliminary Results are Encouraging
por: Törüner, Murat, et al.
Publicado: (2013)

The optimal time to perform an ophthalmic examination of patients with inflammatory bowel disease
por: Biancardi, Ana Luiza, et al.
Publicado: (2019)

Outcome of Immediate Dose Optimization of Infliximab in Inflammatory Bowel Disease Patients
por: Bacsur, Péter, et al.
Publicado: (2021)

Diet and nutrition against inflammatory bowel disease: Trick or treat(ment)?
por: Greco, Salvatore, et al.
Publicado: (2022)

The Coronavirus Might be Paradoxically Beneficial on the Risk of Autism
por: Dutheil, Frédéric, et al.
Publicado: (2020)

Administration of thiamazole for Graves’ disease might trigger the onset of type 1 diabetes
por: Mizutani, Gen, et al.
Publicado: (2018)

Nodular regenerative hyperplasia in inflammatory bowel disease patients with allopurinol–thiopurine cotherapy
por: Simsek, Melek, et al.
Publicado: (2018)

Response to Comments on the CAG/CCC Position Statement on Biosimilars for Inflammatory Bowel Disease
por: Moayyedi, Paul, et al.
Publicado: (2020)

COVID-19 and Inflammatory Bowel Disease: Questions on Incidence, Severity, and Impact of Treatment?
por: Caron, Benedicte, et al.
Publicado: (2020)

Immunosuppressive regimens and outcomes of inflammatory bowel disease patients requiring kidney transplantation
por: Singh, Urvashi, et al.
Publicado: (2022)

Therapeutic drug monitoring in inflammatory bowel disease: At the right time in the right place
por: Truta, Brindusa
Publicado: (2022)

Thiopurines are an independent risk factor for active tuberculosis in inflammatory bowel disease patients
por: Fortes, Flora Maria Lorenzo, et al.
Publicado: (2023)

Tuberculous empyema: combined intrapleural therapy might be an alternative
por: Colares, Philippe de Figueiredo Braga, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oeah3ft59lntjofe0c79dp9iga